Niraparib for maintenance treatment of relapsed, platinum-sensitive ovarian, fallopian tube and peritoneal cancer

  • Technology appraisal guidance
  • TA528
  • Published: 

This guidance has been updated and replaced by NICE technology appraisal guidance 784.